Anatol Kreitzer, Chief Discovery Officer at MapLight Therapeutics, Inc. (MPLT), sold 12,248 shares at $7.84 ($96K) on 2026-10-15, disclosed to the SEC on 2026-10-16.
Open-market sale of $96k MPLT by Chief Discovery Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| MPLT | SELL | 2026-04-17 | $88K | — | Filing → |